Understanding drug resistance in hospital-acquired klebsiella infections
Part of Infections clinical trials.
This study looks at how Klebsiella pneumoniae bacteria that are resistant to many antibiotics form a protective layer (biofilm) and pump out drugs (efflux pump activity). By understanding these mechanisms, doctors may find better ways to treat these tough infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your loved one must have an infection that started while in a hospital.
- The infection must be caused by a type of bacteria called Klebsiella pneumoniae.
- The bacteria must be resistant to many antibiotics (multi-drug resistant).
- You must not have taken antibiotics in the 48 to 72 hours before joining the study.
- You should not have an infection with more than one type of bacteria at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a new antibiotic (cefiderocol) works against a tough type of Klebsiella pneumoniae bacteria that is resistant to many other antibiotics. It may help find better treatments for serious infections.
This study looks at bacteria called Pseudomonas aeruginosa that cause infections. It checks how these bacteria resist antibiotics by studying their genes and ability to form biofilms, which might help find better treatments.
This trial tests a new antibiotic combination (ceftazidime-avibactam) for infections caused by a resistant bacteria called Klebsiella pneumoniae. It aims to see how well this drug works against these hard-to-treat infections.
This study looks at hospital wastewater to predict outbreaks of antibiotic-resistant bacteria. To take part, you must have a confirmed infection from such bacteria while in one of four specific hospital areas.
This study looks at new ways to fight antibiotic-resistant bacteria in people with certain common infections. It may help by testing approaches tailored to the specific germs found in your urine, lungs, or deeper infections.
This study looks at how common Klebsiella pneumoniae bacteria are in patients in the respiratory ICU. If you have this infection, the study may help doctors understand how many people get it and how it affects them.
Hear when a new Multidrug Resistant Klebsiella Pneumoniae Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.